Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Pelvis and Ureter Urothelial Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07630155
What this trial is testing

Office-Based Ureteroscopy Utilizing a Single Use Digital, Flexible Ureteroscope for Upper Tract Urothelial Carcinoma

Who this might be right for
Renal Pelvis and Ureter Urothelial Carcinoma
University of Michigan Rogel Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT01089088
What this trial is testing

Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Cardiff University 63
Testing effectiveness (Phase 2)UnknownNCT01118039
What this trial is testing

Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Hospital del Mar 41
Testing effectiveness (Phase 2)Study completedNCT00053209
What this trial is testing

Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Eastern Cooperative Oncology Group 46
Testing effectiveness (Phase 2)Ended earlyNCT00004856
What this trial is testing

Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium

Who this might be right for
Distal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterProximal Urethral Cancer+6 more
National Cancer Institute (NCI) 40
Not applicableStudy completedNCT02326909
What this trial is testing

Diagnostic Accuracy of Optical Coherence Tomography in Upper Urinary Tract Urothelial Carcinoma

Who this might be right for
Transitional Cell Carcinoma of Urinary Tract
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 26
Not applicableAvailableNCT05494411
What this trial is testing

Named Patient Program for Mitomycin for Pyelocalyceal Solution

Who this might be right for
Urothelial Cancer of Renal PelvisUrothelial Carcinoma of the Renal Pelvis and UreterUrothelial Carcinoma Ureter+3 more
UroGen Pharma Ltd.
Large-scale testing (Phase 3)Looking for participantsNCT04628767
What this trial is testing

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

Who this might be right for
Renal Pelvis and Ureter Urothelial Carcinoma
National Cancer Institute (NCI) 131
Testing effectiveness (Phase 2)Active Not RecruitingNCT05868265
What this trial is testing

Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

Who this might be right for
Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center 9
Large-scale testing (Phase 3)Looking for participantsNCT06774131
What this trial is testing

Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

Who this might be right for
Upper Urinary Tract Urothelial CarcinomaUrothelial Carcinoma
UroGen Pharma Ltd. 70
Testing effectiveness (Phase 2)Ended earlyNCT00112905
What this trial is testing

Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium

Who this might be right for
Adenocarcinoma of the BladderDistal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+10 more
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Study completedNCT00045630
What this trial is testing

S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
SWOG Cancer Research Network 77
Testing effectiveness (Phase 2)Active Not RecruitingNCT04848519
What this trial is testing

Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma

Who this might be right for
Locally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+11 more
Emory University 6
Testing effectiveness (Phase 2)Study completedNCT01328574
What this trial is testing

TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaUreteral NeoplasmsUreter Cancer+2 more
National Cancer Institute (NCI) 13
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Testing effectiveness (Phase 2)Looking for participantsNCT06354231
What this trial is testing

DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC

Who this might be right for
Renal InsufficiencyUpper Urinary Tract Urothelial CarcinomaSolitary Kidney
Fudan University 20
Not applicableUnknownNCT06427993
What this trial is testing

Urine DNA Methylation Detection for Hematuria Evaluation

Who this might be right for
HematuriaUrothelial CarcinomaBladder Cancer+2 more
Changhai Hospital 71
Testing effectiveness (Phase 2)Study completedNCT00006376
What this trial is testing

R115777 in Treating Patients With Advanced Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
H. Lee Moffitt Cancer Center and Research Institute
Early research (Phase 1)Active Not RecruitingNCT06238479
What this trial is testing

LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more
Eli Lilly and Company 490
Large-scale testing (Phase 3)Not Yet RecruitingNCT05810623
What this trial is testing

Single-Dose Intravesical Chemotherapy After Diagnostic URS

Who this might be right for
Upper Urinary Tract Urothelial CarcinomaBladder Cancer
David D'Andrea 394
Next Page